RMT - Latest News
Royce Micro-Cap Trust, Inc. (RMT), operates in Financial Services / Asset Management, trades on NYSE.
Market capitalization stands near $732.1M.
The article list below shows the most recent RMT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RMT Headlines
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share
gurufocus.com - Jun 1, 2026
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share
prnewswire.com - Jun 1, 2026
NEW YORK, June 1, 2026 /PRNewswire/ -- Royce Micro-Cap Trust, Inc. (NYSE-RMT) has declared a quarterly distribution of $0.
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
gurufocus.com - May 20, 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026 PR Newswire NEW YORK, May 20, 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
prnewswire.com - May 20, 2026
NEW YORK, May 20, 2026 /PRNewswire/ -- Average weekly trading volume of approximately 641,137 shares Fund's adviser has more than 50 years of small- a
Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026
globenewswire.com - May 12, 2026
RTX001 is an engineered Regenerative Macrophage Therapy for end-stage liver disease (ESLD) with anti-inflammatory and anti-fibrotic properties These n
Frequently asked RMT news questions
- What is the latest RMT news headline?
- The most recent RMT headline (Jun 1, 2026) is "Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RMT news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RMT news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RMT options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.